1 terminated, 1 withdrawn. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Withdrawn 1 |
Follow Hyperfractionated Total Body Irradiation: new trials by email Literature Review of Hyperfractionated Total Body Irradiation trials Research Report on Hyperfractionated Total Body Irradiation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies CliniMACS, Bone Marrow Transplant, Hyperfractionated Total Body Irradiation - Hematologic Diseases, Hematologic Malignancy | Phase 2 | Withdrawn | Baptist Health South Florida | 2022-09-01 | 2022-09-27 | |
| Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors Hyperfractionated total body irradiation, Thiotepa, Cyclophosphamide - Acute Lymphoid Leukemia (ALL), Acute Myeloid Leukemia (AML) | Phase 2 | Terminated | Memorial Sloan Kettering Cancer Center | 9 | 2018-07-25 | 2025-04-06 |
Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hodgkin Disease (1) · Lymphoma, Non-Hodgkin (1)
Baptist Health South Florida (1) · Memorial Sloan Kettering Cancer Center (1)
United States (2)
Brian Shaffer, MD (1) · Guenther Koehne, MD (1)